Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin

OBJECTIVES: To evaluate the risk of symptomatic venous thromboembolism (VTE) recurrence at 3 months in relation to treatment duration, according to baseline risk factor profiles, in patients with superficial vein thrombosis (SVT) treated with intermediate dose of tinzaparin. METHODS: We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Karathanos, Christos, Kakkos, Stavros K, Georgiadis, Georgios, Ioannou, Christos, Vasdekis, Spyros, Chatzis, Dimitrios, Latzios, Panagiotis, Giannoukas, Athanasios D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070553/
https://www.ncbi.nlm.nih.gov/pubmed/36461172
http://dx.doi.org/10.1177/02683555221143576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070553/
https://www.ncbi.nlm.nih.gov/pubmed/36461172
http://dx.doi.org/10.1177/02683555221143576

Ejemplares similares